Table 4.
Prior literature on nodal presentation at diagnosis or subsequent nodal recurrence in patients with sinonasal undifferentiated carcinoma (SNUC) or sinonasal small-cell carcinoma in those who initially presented with N0 disease
| Author/institution | Site/histology | (n, evaluable) | Initial nodal involvement | Subsequent nodal recurrence (no elective treatment or no information), initial N0 | Subsequent nodal recurrence (initial elective treatment), initial N0 |
|---|---|---|---|---|---|
| Rosenthal et al,14 MD Anderson | Small cell | 7 | 3/7 (43%) | 3/4 (75%) | N/R |
| Perez-Ordonez et al,15 Memorial Sloan-Kettering | Small cell | 6 | 0/6 | 0/6 | N/R |
| Babin et al,16 France | Small cell | 21 | 0/21 | 2/15 (13%) | 1/6 (17%) |
| Kameya et al,17 Tokyo | Small cell | 4 | 1/4 (25%) | 2/3 (67%) | N/A |
| Total evaluable (sinonasal small cell carcinoma) | 38 | 4/38 (11%) | 7/28 (25%) | 1/6 (17%) | |
| Total sinonasal small cell carcinoma (including current study) | 67 | 8/67 (12%) | |||
| Cerilli et al,18 UVA | SNUC | 25 | 1/25 (4%) | 8/15 (53%) | N/A |
| Jeng et al,19 Taiwan | SNUC | 36 | 6/36 (17%) | N/R | N/R |
| Rischin et al,20 Peter MacCallum | SNUC | 10 | 3/10 (30%) | N/R | N/R |
| Al-Mamgani et al,21 Erasmus | SNUC | 21 | 2/21 (9.5%) | 2/11 (18%) | 0/8 |
| Chen et al,22 UCSF | SNUC | 21 | 2/21 (9.5%) | 1/4 (25%) | 1/15 (6.7%) |
| Kim et al,23 UCLA | SNUC | 8 | 0/8 | 2/5 (40%) | 0/3 |
| Tanzler et al,24 University of Florida | SNUC | 15 | 2/15 (13%) | 2/6 (33%) | 0/7 |
| Total evaluable (SNUC) | 127 | 16/136 (12%) | 15/41 (37%) | 1/33 (3.0%) | |
| Total SNUC (including current study) | 239 | 34/239 (14%) |
N/A, not applicable; N/R, not reported; UCLA, the University of California at Los Angeles; UCSF, the University of California at San Francisco; UVA, the University of Virginia.